Mcl-1; the molecular regulation of protein function

FEBS Letters

Volumn 584, Issue 14, 2010, Pages 2981-2989

  Thomas, Luke W ^a   Lam, Connie ^a   Edwards, Steven W ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Apoptosis; Myeloid cell leukemia 1; Phosphorylation; Post translational modification

Indexed keywords

PROTEIN BCL 2; PROTEIN MCL 1; SERINE; THREONINE; PROTEIN;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; APOPTOSIS; CARCINOGENESIS; CELL FATE; DEGENERATIVE DISEASE; DIMERIZATION; HEMATOLOGIC MALIGNANCY; HUMAN; INFLAMMATION; MOLECULAR DYNAMICS; MULTIPLE SCLEROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; REGULATORY MECHANISM; REVIEW; SOLID TUMOR; UBIQUITINATION; B CELL LYMPHOMA; B LYMPHOCYTE; BONE MARROW CELL; GENETICS; LEUKEMIA; METABOLISM; MYELOID LEUKEMIA; MYELOID PROGENITOR CELL; PHOSPHORYLATION; PROTEIN TERTIARY STRUCTURE;

APOPTOSIS; B-LYMPHOCYTES; DIMERIZATION; HUMANS; LEUKEMIA; LEUKEMIA, MYELOID; LYMPHOMA, B-CELL; MYELOID CELLS; MYELOID PROGENITOR CELLS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; PROTEINS;

EID: 77954175674     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.05.061     Document Type: Review

References (82)

1. Adams J.M., Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007, 26(9):1324-1337.
2. Brenner D., Mak T.W. Mitochondrial cell death effectors. Curr. Opin. Cell Biol. 2009, 21(6):871-877.
3. Kozopas K.M., et al. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc. Natl Acad. Sci. USA 1993, 90(8):3516-3520.
4. Vaux D.L., Cory S., Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988, 335(6189):440-442.
5. Lutz R.J. Role of the BH3 (Bcl-2 homology 3) domain in the regulation of apoptosis and Bcl-2-related proteins. Biochem. Soc. Trans. 2000, 28(2):51-56.
6. Day C.L., et al. Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands. J. Biol. Chem. 2005, 280(6):4738-4744.
7. Chen L., et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol. Cell 2005, 17(3):393-403.
8. Day C.L., et al. Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1. J. Mol. Biol. 2008, 380(5):958-971.
9. Akgul C., et al. In vivo localisation and stability of human Mcl-1 using green fluorescent protein (GFP) fusion proteins. FEBS Lett. 2000, 478(1-2):72-76.
10. Yang T., Kozopas K.M., Craig R.W. The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2. J. Cell Biol. 1995, 128(6):1173-1184.
11. Sorenson C.M. Bcl-2 family members and disease. Biochim. Biophys. Acta 2004, 1644(2-3):169-177.
12. Krajewski S., et al. Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am. J. Pathol. 1995, 146(6):1309-1319.
13. Rinkenberger J.L., et al. Mcl-1 deficiency results in peri-implantation embryonic lethality. Genes Dev. 2000, 14(1):23-27.
14. Veis D.J., et al. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993, 75(2):229-240.
15. Opferman J.T., et al. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 2003, 426(6967):671-676.
16. Arbour N., et al. Mcl-1 is a key regulator of apoptosis during CNS development and after DNA damage. J. Neurosci. 2008, 28(24):6068-6078.
17. Steimer D.A., et al. Selective roles for antiapoptotic MCL-1 during granulocyte development and macrophage effector function. Blood 2009, 113(12):2805-2815.
18. Edwards S.W., et al. Regulation of neutrophil apoptosis by Mcl-1. Biochem. Soc. Trans. 2004, 32(Pt 3):489-492.
19. Opferman J.T., et al. Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science 2005, 307(5712):1101-1104.
20. Liu H., et al. Mcl-1 is essential for the survival of synovial fibroblasts in rheumatoid arthritis. J. Immunol. 2005, 175(12):8337-8345.
21. Maddika S., et al. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist. Update 2007, 10(1-2):13-29.
22. Jamil S., et al. A proteolytic fragment of Mcl-1 exhibits nuclear localization and regulates cell growth by interaction with Cdk1. Biochem. J. 2005, 387(Pt 3):659-667.
23. Fujise K., et al. Regulation of apoptosis and cell cycle progression by MCL1. Differential role of proliferating cell nuclear antigen. J. Biol. Chem. 2000, 275(50):39458-39465.
24. Jamil S., et al. An essential role for MCL-1 in ATR-mediated CHK1 phosphorylation. Mol. Biol. Cell 2008, 19(8):3212-3220.
25. Bodrug S.E., et al. Biochemical and functional comparisons of Mcl-1 and Bcl-2 proteins: evidence for a novel mechanism of regulating Bcl-2 family protein function. Cell Death Differ. 1995, 2(3):173-182.
26. Wang J.M., et al. The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB. Mol. Cell. Biol. 1999, 19(9):6195-6206.
27. Huang H.M., Huang C.J., Yen J.J. Mcl-1 is a common target of stem cell factor and interleukin-5 for apoptosis prevention activity via MEK/MAPK and PI-3K/Akt pathways. Blood 2000, 96(5):1764-1771.
28. Jourdan M., et al. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1. Cell Death Differ. 2000, 7(12):1244-1252.
29. Chao J.R., et al. Mcl-1 is an immediate-early gene activated by the granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling pathway and is one component of the GM-CSF viability response. Mol. Cell. Biol. 1998, 18(8):4883-4898.
30. Leu C.M., Chang C., Hu C. Epidermal growth factor (EGF) suppresses staurosporine-induced apoptosis by inducing mcl-1 via the mitogen-activated protein kinase pathway. Oncogene 2000, 19(13):1665-1675.
31. Le Gouill S., et al. VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis. Blood 2004, 104(9):2886-2892.
32. Akgul C., et al. Functional analysis of the human MCL-1 gene. Cell. Mol. Life Sci. 2000, 57(4):684-691.
33. Puthier D., Bataille R., Amiot M. IL-6 up-regulates mcl-1 in human myeloma cells through JAK/STAT rather than ras/MAP kinase pathway. Eur. J. Immunol. 1999, 29(12):3945-3950.
34. Lee Y.K., et al. VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance. Leukemia 2005, 19(4):513-523.
35. Liu H., et al. Serine phosphorylation of STAT3 is essential for Mcl-1 expression and macrophage survival. Blood 2003, 102(1):344-352.
36. Wang J.M., Lai M.Z., Yang-Yen H.F. Interleukin-3 stimulation of mcl-1 gene transcription involves activation of the PU.1 transcription factor through a p38 mitogen-activated protein kinase-dependent pathway. Mol. Cell. Biol. 2003, 23(6):1896-1909.
37. Townsend K.J., et al. Regulation of MCL1 through a serum response factor/Elk-1-mediated mechanism links expression of a viability-promoting member of the BCL2 family to the induction of hematopoietic cell differentiation. J. Biol. Chem. 1999, 274(3):1801-1813.
38. Liu X.H., et al. HIF-1alpha has an anti-apoptotic effect in human airway epithelium that is mediated via Mcl-1 gene expression. J. Cell. Biochem. 2006, 97(4):755-765.
39. Iglesias-Serret D., et al. Transcriptional and translational control of Mcl-1 during apoptosis. Arch. Biochem. Biophys. 2003, 417(2):141-152.
40. Nijhawan D., et al. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev. 2003, 17(12):1475-1486.
41. Croxton R., et al. Direct repression of the Mcl-1 promoter by E2F1. Oncogene 2002, 21(9):1359-1369.
42. Kim J.H., et al. MCL-1ES, a novel variant of MCL-1, associates with MCL-1L and induces mitochondrial cell death. FEBS Lett. 2009, 583(17):2758-2764.
43. Bae J., et al. MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain. J. Biol. Chem. 2000, 275(33):25255-25261.
44. Marriott H.M., et al. Dynamic changes in Mcl-1 expression regulate macrophage viability or commitment to apoptosis during bacterial clearance. J. Clin. Invest. 2005, 115(2):359-368.
45. Mott J.L., et al. Mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007, 26(42):6133-6140.
46. Subramaniam D., et al. Translation inhibition during cell cycle arrest and apoptosis: Mcl-1 is a novel target for RNA binding protein CUGBP2. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294(4):G1025-G1032.
47. Fadeel B., Orrenius S. Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J. Intern. Med. 2005, 258(6):479-517.
48. Rohn, T.T., The role of caspases in Alzheimer's disease; potential novel therapeutic opportunities. Apoptosis. http://www.springerlink.com/content/p27q523882g4238r/.
49. Das A., et al. Activation of calpain and caspase pathways in demyelination and neurodegeneration in animal model of multiple sclerosis. CNS Neurol. Disord.: Drug Targets 2008, 7(3):313-320.
50. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100(1):57-70.
51. Aichberger K.J., et al. Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides. Blood 2005, 105(8):3303-3311.
52. Le Gouill S., et al. Mcl-1 regulation and its role in multiple myeloma. Cell Cycle 2004, 3(10):1259-1262.
53. Breitenbuecher F., et al. A novel molecular mechanism of primary resistance to FLT3-kinase inhibitors in AML. Blood 2009, 113(17):4063-4073.
54. Fleischer B., et al. Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma. Int. J. Oncol. 2006, 28(1):25-32.
55. Henson E.S., Hu X., Gibson S.B. Herceptin sensitizes ErbB2-overexpressing cells to apoptosis by reducing antiapoptotic Mcl-1 expression. Clin. Cancer Res. 2006, 12(3 Pt 1):845-853.
56. Song L., et al. Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells. Cancer Biol. Ther. 2005, 4(3):267-276.
57. Fu J.R., et al. The effects of Mcl-1 gene on ATRA-resistant HL-60 cell. Zhonghua Xue Ye Xue Za Zhi 2005, 26(6):352-354.
58. Thallinger C., et al. Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamide. Clin. Cancer Res. 2004, 10(12 Pt 1):4185-4191.
59. van Delft M.F., et al. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 2006, 10(5):389-399.
60. Zhou P., et al. MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes. Blood 2001, 97(12):3902-3909.
61. Moulding D.A., et al. Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cells. Blood 2000, 96(5):1756-1763.
62. Akgul C. Mcl-1 is a potential therapeutic target in multiple types of cancer. Cell. Mol. Life Sci. 2009, 66(8):1326-1336.
63. Derouet M., et al. Granulocyte macrophage colony-stimulating factor signaling and proteasome inhibition delay neutrophil apoptosis by increasing the stability of Mcl-1. J. Biol. Chem. 2004, 279(26):26915-26921.
64. Zhong Q., et al. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 2005, 121(7):1085-1095.
65. Ding Q., et al. Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization. Mol. Cell. Biol. 2007, 27(11):4006-4017.
66. Schwickart M., et al. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 2010, 463(7277):103-107.
67. Weng C., et al. Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells. J. Biol. Chem. 2005, 280(11):10491-10500.
68. Clohessy J.G., Zhuang J., Brady H.J. Characterisation of Mcl-1 cleavage during apoptosis of haematopoietic cells. Br. J. Haematol. 2004, 125(5):655-665.
69. Han J., et al. Degradation of Mcl-1 by granzyme B: implications for Bim-mediated mitochondrial apoptotic events. J. Biol. Chem. 2004, 279(21):22020-22029.
70. Herrant M., et al. Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis. Oncogene 2004, 23(47):7863-7873.
71. Han J., et al. Disruption of Mcl-1.Bim complex in granzyme B-mediated mitochondrial apoptosis. J. Biol. Chem. 2005, 280(16):16383-16392.
72. Leuenroth S.J., et al. The loss of Mcl-1 expression in human polymorphonuclear leukocytes promotes apoptosis. J. Leukoc. Biol. 2000, 68(1):158-166.
73. Germain M., Duronio V. The N terminus of the anti-apoptotic BCL-2 homologue MCL-1 regulates its localization and function. J. Biol. Chem. 2007, 282(44):32233-32242.
74. Chou C.H., Lee R.S., Yang-Yen H.F. An internal EELD domain facilitates mitochondrial targeting of Mcl-1 via a Tom70-dependent pathway. Mol. Biol. Cell 2006, 17(9):3952-3963.
75. Kobayashi S., et al. Serine 64 phosphorylation enhances the antiapoptotic function of Mcl-1. J. Biol. Chem. 2007, 282:18407-18417.
76. Ding Q., et al. Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer. Cancer Res. 2008, 68(15):6109-6117.
77. Inoshita S., et al. Phosphorylation and inactivation of myeloid cell leukemia 1 by JNK in response to oxidative stress. J. Biol. Chem. 2002, 277(46):43730-43734.
78. Kodama Y., et al. Antiapoptotic effect of c-Jun N-terminal kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis. Gastroenterology 2009, 136(4):1423-1434.
79. Maurer U., et al. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol. Cell 2006, 21(6):749-760.
80. Morel C., et al. Mcl-1 integrates the opposing actions of signaling pathways that mediate survival and apoptosis. Mol. Cell. Biol. 2009, 29(14):3845-3852.
81. Doble B.W., Woodgett J.R. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 2003, 116(Pt 7):1175-1186.
82. Domina A.M., et al. MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol. Oncogene 2004, 23(31):5301-5315.